{
    "contributors": null,
    "coordinates": null,
    "created_at": "Wed Oct 21 11:16:53 +0000 2015",
    "entities": {
        "hashtags": [
            {
                "indices": [
                    115,
                    125
                ],
                "text": "immunoonc"
            }
        ],
        "symbols": [],
        "urls": [
            {
                "display_url": "bit.ly/1NmNG4O",
                "expanded_url": "http://bit.ly/1NmNG4O",
                "indices": [
                    126,
                    140
                ],
                "url": "https://t.co/RAXjptUfMf"
            }
        ],
        "user_mentions": [
            {
                "id": 2260514101,
                "id_str": "2260514101",
                "indices": [
                    3,
                    19
                ],
                "name": "Novartis Science",
                "screen_name": "NovartisScience"
            }
        ]
    },
    "favorite_count": 0,
    "favorited": false,
    "geo": null,
    "id": 656791261043642368,
    "id_str": "656791261043642368",
    "in_reply_to_screen_name": null,
    "in_reply_to_status_id": null,
    "in_reply_to_status_id_str": null,
    "in_reply_to_user_id": null,
    "in_reply_to_user_id_str": null,
    "is_quote_status": false,
    "lang": "en",
    "metadata": {
        "iso_language_code": "en",
        "result_type": "recent"
    },
    "place": null,
    "possibly_sensitive": false,
    "retweet_count": 15,
    "retweeted": false,
    "retweeted_status": {
        "contributors": null,
        "coordinates": null,
        "created_at": "Wed Oct 21 11:15:57 +0000 2015",
        "entities": {
            "hashtags": [
                {
                    "indices": [
                        94,
                        104
                    ],
                    "text": "immunoonc"
                }
            ],
            "symbols": [],
            "urls": [
                {
                    "display_url": "bit.ly/1NmNG4O",
                    "expanded_url": "http://bit.ly/1NmNG4O",
                    "indices": [
                        105,
                        128
                    ],
                    "url": "https://t.co/RAXjptUfMf"
                }
            ],
            "user_mentions": []
        },
        "favorite_count": 14,
        "favorited": false,
        "geo": null,
        "id": 656791023134351360,
        "id_str": "656791023134351360",
        "in_reply_to_screen_name": null,
        "in_reply_to_status_id": null,
        "in_reply_to_status_id_str": null,
        "in_reply_to_user_id": null,
        "in_reply_to_user_id_str": null,
        "is_quote_status": false,
        "lang": "en",
        "metadata": {
            "iso_language_code": "en",
            "result_type": "recent"
        },
        "place": null,
        "possibly_sensitive": false,
        "retweet_count": 15,
        "retweeted": false,
        "source": "<a href=\"http://twitter.com\" rel=\"nofollow\">Twitter Web Client</a>",
        "text": "We plan to advance five more immuno-oncology programs into clinical trials by the end of 2016 #immunoonc https://t.co/RAXjptUfMf",
        "truncated": false,
        "user": {
            "contributors_enabled": false,
            "created_at": "Tue Dec 24 17:12:27 +0000 2013",
            "default_profile": false,
            "default_profile_image": false,
            "description": "Official Twitter site of the Novartis Institutes for BioMedical Research. See our community guidelines: http://t.co/sIutopdaWk",
            "entities": {
                "description": {
                    "urls": [
                        {
                            "display_url": "bit.ly/1Mwr7cf",
                            "expanded_url": "http://bit.ly/1Mwr7cf",
                            "indices": [
                                104,
                                126
                            ],
                            "url": "http://t.co/sIutopdaWk"
                        }
                    ]
                },
                "url": {
                    "urls": [
                        {
                            "display_url": "nibr.com",
                            "expanded_url": "http://www.nibr.com",
                            "indices": [
                                0,
                                22
                            ],
                            "url": "http://t.co/ZszaCV1rBb"
                        }
                    ]
                }
            },
            "favourites_count": 184,
            "follow_request_sent": false,
            "followers_count": 8890,
            "following": false,
            "friends_count": 581,
            "geo_enabled": false,
            "has_extended_profile": false,
            "id": 2260514101,
            "id_str": "2260514101",
            "is_translation_enabled": false,
            "is_translator": false,
            "lang": "en",
            "listed_count": 179,
            "location": "Global",
            "name": "Novartis Science",
            "notifications": false,
            "profile_background_color": "923222",
            "profile_background_image_url": "http://pbs.twimg.com/profile_background_images/378800000180808357/fYvueu7l.png",
            "profile_background_image_url_https": "https://pbs.twimg.com/profile_background_images/378800000180808357/fYvueu7l.png",
            "profile_background_tile": false,
            "profile_banner_url": "https://pbs.twimg.com/profile_banners/2260514101/1437783556",
            "profile_image_url": "http://pbs.twimg.com/profile_images/624744047912030208/BuVCHJq9_normal.jpg",
            "profile_image_url_https": "https://pbs.twimg.com/profile_images/624744047912030208/BuVCHJq9_normal.jpg",
            "profile_link_color": "E44C16",
            "profile_sidebar_border_color": "FFFFFF",
            "profile_sidebar_fill_color": "DDEEF6",
            "profile_text_color": "333333",
            "profile_use_background_image": true,
            "protected": false,
            "screen_name": "NovartisScience",
            "statuses_count": 1340,
            "time_zone": "Atlantic Time (Canada)",
            "url": "http://t.co/ZszaCV1rBb",
            "utc_offset": -10800,
            "verified": true
        }
    },
    "source": "<a href=\"http://www.hootsuite.com\" rel=\"nofollow\">Hootsuite</a>",
    "text": "RT @NovartisScience: We plan to advance five more immuno-oncology programs into clinical trials by the end of 2016 #immunoonc https://t.co/\u2026",
    "truncated": false,
    "user": {
        "contributors_enabled": false,
        "created_at": "Fri Nov 07 04:52:06 +0000 2008",
        "default_profile": false,
        "default_profile_image": false,
        "description": "We provide healthcare solutions that address the evolving needs of patients & societies worldwide. See our community guidelines: http://t.co/ErbRQenyRj",
        "entities": {
            "description": {
                "urls": [
                    {
                        "display_url": "bit.ly/ZeuuT3",
                        "expanded_url": "http://bit.ly/ZeuuT3",
                        "indices": [
                            129,
                            151
                        ],
                        "url": "http://t.co/ErbRQenyRj"
                    }
                ]
            },
            "url": {
                "urls": [
                    {
                        "display_url": "novartis.com",
                        "expanded_url": "http://novartis.com",
                        "indices": [
                            0,
                            22
                        ],
                        "url": "http://t.co/cCcmWeeHSD"
                    }
                ]
            }
        },
        "favourites_count": 177,
        "follow_request_sent": false,
        "followers_count": 165778,
        "following": false,
        "friends_count": 438,
        "geo_enabled": false,
        "has_extended_profile": false,
        "id": 17226612,
        "id_str": "17226612",
        "is_translation_enabled": false,
        "is_translator": false,
        "lang": "en",
        "listed_count": 2325,
        "location": "140+ countries",
        "name": "Novartis",
        "notifications": false,
        "profile_background_color": "FCB017",
        "profile_background_image_url": "http://pbs.twimg.com/profile_background_images/437780731423518720/KyjfmouP.jpeg",
        "profile_background_image_url_https": "https://pbs.twimg.com/profile_background_images/437780731423518720/KyjfmouP.jpeg",
        "profile_background_tile": false,
        "profile_banner_url": "https://pbs.twimg.com/profile_banners/17226612/1443569879",
        "profile_image_url": "http://pbs.twimg.com/profile_images/537380603239202816/fUQmgECF_normal.png",
        "profile_image_url_https": "https://pbs.twimg.com/profile_images/537380603239202816/fUQmgECF_normal.png",
        "profile_link_color": "E44D16",
        "profile_sidebar_border_color": "FFFFFF",
        "profile_sidebar_fill_color": "F5EBD7",
        "profile_text_color": "634329",
        "profile_use_background_image": false,
        "protected": false,
        "screen_name": "Novartis",
        "statuses_count": 8614,
        "time_zone": "Bern",
        "url": "http://t.co/cCcmWeeHSD",
        "utc_offset": 3600,
        "verified": true
    }
}